Home › Compare › TRXPF vs BTI

TRXPF vs BTI: Dividend Comparison 2026

TRXPF yields 3.27% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TRXPF wins by $634.90M in total portfolio value
10 years
TRXPF
TRXPF
● Live price
3.27%
Share price
$24.57
Annual div
$0.80
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$634.94M
Annual income
$599,684,359.43
Full TRXPF calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — TRXPF vs BTI

📍 TRXPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTRXPFBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TRXPF + BTI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
TRXPF pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TRXPF
Annual income on $10K today (after 15% tax)
$277.78/yr
After 10yr DRIP, annual income (after tax)
$509,731,705.52/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, TRXPF beats the other by $509,729,336.87/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TRXPF + BTI for your $10,000?

TRXPF: 50%BTI: 50%
100% BTI50/50100% TRXPF
Portfolio after 10yr
$317.49M
Annual income
$299,843,573.03/yr
Blended yield
94.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

TRXPF
No analyst data
Altman Z
5.8
Piotroski
3/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TRXPF buys
0
BTI buys
0
No recent congressional trades found for TRXPF or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTRXPFBTI
Forward yield3.27%5.38% ✓
Annual dividend / share$0.80$3.15 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100% ✓11.3%
Portfolio after 10y$634.94M ✓$37.7K
Annual income after 10y$599,684,359.43 ✓$2,786.64
Total dividends collected$632.35M ✓$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: TRXPF vs BTI ($10,000, DRIP)

YearTRXPF PortfolioTRXPF Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$11,354$653.59$11,299$598.92+$55.00 → TRXPF
2$13,535$1,387.04$12,794$703.91+$741.00 → TRXPF
3$17,574$3,090.80$14,518$829.07+$3.1K → TRXPF
4$26,305$7,500.82$16,513$978.64+$9.8K → TRXPF
5$49,132$20,985.78$18,827$1,157.84+$30.3K → TRXPF
6$125,837$73,265.77$21,518$1,373.12+$104.3K → TRXPF
7$485,391$350,745.93$24,657$1,632.46+$460.7K → TRXPF
8$3,048,220$2,528,851.81$28,329$1,945.74+$3.02M → TRXPF
9$32,945,707$29,684,110.82$32,637$2,325.33+$32.91M → TRXPF
10$634,936,266$599,684,359.43$37,708$2,786.64+$634.90M → TRXPF

TRXPF vs BTI: Complete Analysis 2026

TRXPF — Stock

Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; allergen immunotherapy tablets comprising CEDARCURE and MITICURE; and CORECTIM, a topical janus kinase (JAK) inhibitor. It markets its products primarily through medical representatives for medical professionals. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.

Full TRXPF Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this TRXPF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TRXPF vs SCHDTRXPF vs JEPITRXPF vs OTRXPF vs KOTRXPF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.